-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HmrmRGffyX7FeRiHdSLpSutM2U4E6jSBpCe/aR5FetlSX6OC/cSN5AslDPo/H+YY GMqdBCjOY51MjdtpMv6u0Q== 0000950134-99-003044.txt : 19990419 0000950134-99-003044.hdr.sgml : 19990419 ACCESSION NUMBER: 0000950134-99-003044 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19990402 ITEM INFORMATION: FILED AS OF DATE: 19990416 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMARILLO BIOSCIENCES INC CENTRAL INDEX KEY: 0001014763 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 751974352 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 000-20791 FILM NUMBER: 99595978 BUSINESS ADDRESS: STREET 1: 800 W 9TH AVE CITY: AMARILLO STATE: TX ZIP: 79101-3206 BUSINESS PHONE: 8063761741 MAIL ADDRESS: STREET 1: AMARILLO BIOSCIENCES INC STREET 2: 800 W 9TH AVE CITY: AMARILLO STATE: TX ZIP: 79101-3206 8-K 1 FORM 8-K 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 14(d) OF THE SECURITIES EXCHANGE ACT OF 1934 CONVERSION OF DEBT TO EQUITY DATE OF REPORT: April 2, 1999 EXACT NAME OF REGISTRANT: AMARILLO BIOSCIENCES, INC. ("Issuer") STATE OR OTHER JURISDICTION OF INCORPORATION: Texas COMMISSION FILE NUMBER: 0-20791 IRS EMPLOYER IDENTIFICATION NUMBER: 75-1974352 ADDRESS OF PRINCIPAL EXECUTIVE OFFICES: 800 W. 9th, Amarillo, Texas 79101 REGISTRANT'S TELEPHONE NUMBER: 806/376-1741 ITEM 5: On April 2, 1999, Issuer issued to HAYASHIBARA BIOCHEMICAL LABORATORIES, INC., a Japanese corporation ("HBL"), 946,094 shares of Issuer's common stock, par $.01. In exchange, HBL released a debt owed to it by Issuer in the amount of $2,837,526.00. Prior to the reported transaction, HBL owned 1,232,856 shares out of 5,414,232 outstanding, for an ownership share of 22.8%. In the transaction, HBL acquired 946,094 shares. Therefore, HBL now owns 2,178,950 shares out of 6,360,326 outstanding, for an ownership share of 34.3%. The purpose of this transaction was to eliminate Issuer's expense from interest on the debt owed to HBL. Eliminating this interest expense will assist Issuer in remaining financially viable until it can complete its research and become profitable. 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 16, 1999. AMARILLO BIOSCIENCES, INC. By: /s/ EDWARD L. MORRIS ---------------------------------- Edward L. Morris, Secretary -----END PRIVACY-ENHANCED MESSAGE-----